From Medscape Gastroenterology

Coverage from the

American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

October 21 - 26, 2022; Charlotte, North Carolina/Virtual

October 21 - 26, 2022 Charlotte, North Carolina/Virtual

ACG 2022 RBX2660 Shows Promise in Breaking the Cycle of Recurrent C diff Building on the success seen with fecal microbiota transplantation, this experimental treatment lowered the rates of recurrent C difficile infections.
Medscape Medical News, October 27, 2022
ACG 2022 Guselkumab and Golimumab: Better Together for Ulcerative Colitis People with moderate-to-severe ulcerative colitis benefit from a combination of these monoclonal antibodies, compared with induction with either agent alone, according to a new phase 2a study.
Medscape Medical News, October 26, 2022
ACG 2022 Circulating Tumor DNA Test May Help Guide GI Cancer Management A ctDNA test may be sensitive enough to assess tumor burden and help guide treatment plans for people with locally advanced or metastatic colorectal cancer.
Medscape Medical News, October 23, 2022

Conference News

ACG 2022 Uncomfortable After Eating? Step Into a Virtual World for Help
WebMD Health News, November 2, 2022
ACG 2022 Dupilumab Improves Eosinophilic Esophagitis Up to 24 Weeks
MDedge News, November 1, 2022
ACG 2022 Endoscopic Score Helps Guide Tx in Immune-Mediated Colitis
MDedge News, November 1, 2022
ACG 2022 NAFLD Progresses to Cirrhosis in Young and Old at Similar Rate
MDedge News, November 1, 2022
ACG 2022 Guselkumab Induction Improves Moderate-to-Severe UC at Week 12
MDedge News, October 31, 2022
ACG 2022 High-Quality Index Colonoscopies Pay Off for Low-Risk Patients
MDedge News, October 31, 2022
ACG 2022 Terlipressin Decreases Need for RRT in Liver Transplant Patients
MDedge News, October 31, 2022
ACG 2022 Easier Bowel Prep Formulation Yields Real-World Results
MDedge News, October 31, 2022

ACG 2022 RBX2660 Shows Promise in Breaking the Cycle of Recurrent C diff
Medscape Medical News, October 27, 2022
ACG 2022 EUS-Guided RF Ablation Doubles Survival for Unresectable Pancreatic Cancer
MDedge News, October 27, 2022
ACG 2022 Guselkumab and Golimumab: Better Together for Ulcerative Colitis
Medscape Medical News, October 26, 2022
ACG 2022 Young CRC Patients Missing Out on Genetic Counseling, Testing
MDedge News, October 26, 2022
ACG 2022 Pancreatic Cancer Screening Effective for High-Risk Patients
MDedge News, October 26, 2022
ACG 2022 Risk Factors ID'd for Acute Pancreatitis From Weight-Loss Drugs
Medscape Medical News, October 25, 2022
ACG 2022 IgG-Based Elimination Diet Beneficial for IBS Symptoms: Study
Medscape Medical News, October 24, 2022
ACG 2022 Circulating Tumor DNA Test May Help Guide GI Cancer Management
Medscape Medical News, October 23, 2022

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

ACG 2022: Colorectal Cancer Screening, and GI and Liver Disease
Vivek Kaul, MD
Highlights in Obesity From ACG 2022
Carolyn Newberry, MD
Highlights in Esophageal Research From ACG 2022
Suneel D. Kamath, MD
13 Highlights From ACG 2022
David A. Johnson, MD

Popular News from ACG 2021

Balloon-Enhanced Colonoscopy Finds More Adenomas A head-to-head trial found that the G-EYE balloon detects more adenomas than the Endocuff Vision attachment.
Medscape Medical News, Oct 26, 2021
A Pill for C difficile Works by Increasing Microbiome Diversity Freeze-dried human stool may offer advantages for the treatment of C difficile infections.
Medscape Medical News, Oct 24, 2021
People of Color Missing in Inflammatory Bowel Disease Trials Black, Hispanic, and Native American people are underrepresented in trials of treatments for inflammatory bowel disease.
Medscape Medical News, Nov 05, 2021

Previous Coverage

Related Resources